Utah Medical Net Worth
Utah Medical Net Worth Breakdown | UTMD |
Utah Medical Net Worth Analysis
Utah Medical's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Utah Medical's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Utah Medical's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Utah Medical's net worth analysis. One common approach is to calculate Utah Medical's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Utah Medical's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Utah Medical's net worth. This approach calculates the present value of Utah Medical's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Utah Medical's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Utah Medical's net worth. This involves comparing Utah Medical's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Utah Medical's net worth relative to its peers.
Enterprise Value |
|
To determine if Utah Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Utah Medical's net worth research are outlined below:
| Utah Medical generated a negative expected return over the last 90 days | |
| About 71.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from MacroaxisInsider: Insider Trading |
Utah Medical Quarterly Good Will |
|
Utah Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Utah Medical Products. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Utah Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 23rd of April 2024 Upcoming Quarterly Report | View | |
| 31st of March 2024 Next Fiscal Quarter End | View |
Know Utah Medical's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Utah Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Utah Medical Products backward and forwards among themselves. Utah Medical's institutional investor refers to the entity that pools money to purchase Utah Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Minerva Advisors Llc | 2024-12-31 | 78.4 K | Hotchkis & Wiley Capital Management Llc | 2024-12-31 | 75.2 K | Bank Of New York Mellon Corp | 2024-12-31 | 47.3 K | Acadian Asset Management Llc | 2024-12-31 | 43.2 K | Royce & Associates, Lp | 2024-12-31 | 42 K | Northern Trust Corp | 2024-12-31 | 36.8 K | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 36.4 K | Millennium Management Llc | 2024-12-31 | 32.1 K | Isthmus Partners Llc | 2024-12-31 | 31.5 K | Renaissance Technologies Corp | 2024-12-31 | 221.5 K | Dimensional Fund Advisors, Inc. | 2024-12-31 | 186.7 K |
Follow Utah Medical's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 191.47 M.Market Cap |
|
Project Utah Medical's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.13 | 0.12 | |
| Return On Capital Employed | 0.11 | 0.11 | |
| Return On Assets | 0.11 | 0.20 | |
| Return On Equity | 0.12 | 0.11 |
When accessing Utah Medical's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Utah Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Utah Medical's profitability and make more informed investment decisions.
Please note, the presentation of Utah Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Utah Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Utah Medical's management manipulating its earnings.
Evaluate Utah Medical's management efficiency
Utah Medical Products has return on total asset (ROA) of 0.0762 % which means that it generated a profit of $0.0762 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1129 %, meaning that it created $0.1129 on every $100 dollars invested by stockholders. Utah Medical's management efficiency ratios could be used to measure how well Utah Medical manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Assets is expected to grow to 0.20, whereas Return On Tangible Assets are forecasted to decline to 0.12. At present, Utah Medical's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to 0.95, whereas Non Currrent Assets Other are projected to grow to (1.09).| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 33.52 | 35.20 | |
| Tangible Book Value Per Share | 28.83 | 30.27 | |
| Enterprise Value Over EBITDA | 7.17 | 11.20 | |
| Price Book Value Ratio | 1.83 | 1.74 | |
| Enterprise Value Multiple | 7.17 | 11.20 | |
| Price Fair Value | 1.83 | 1.74 | |
| Enterprise Value | 192.4 M | 202 M |
Utah Medical Products has shown resilience through effective management strategies. Our analysis examines how these strategies influence financial outcomes and investor returns which helps in understanding the stock's long-term potential.
Enterprise Value Revenue 2.679 | Revenue | Quarterly Revenue Growth (0.26) | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Utah Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Utah Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Utah Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Leigh Carrie 22 hours ago Insider Trading | ||
Leigh Carrie a day ago Insider Trading | ||
Leigh Carrie 3 days ago Insider Trading | ||
Leigh Carrie few days ago Insider Trading | ||
Leigh Carrie few days ago Insider Trading | ||
Leigh Carrie six days ago Insider Trading | ||
Leigh Carrie over a week ago Insider Trading | ||
Leigh Carrie over a week ago Insider Trading | ||
Leigh Carrie over a week ago Insider Trading | ||
Leigh Carrie over a week ago Insider Trading | ||
Leigh Carrie over a week ago Insider Trading | ||
Leigh Carrie over two weeks ago Insider Trading |
Utah Medical Corporate Filings
| 5th of February 2025 Other Reports | ViewVerify | |
8K | 28th of January 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F3 | 12th of November 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
F4 | 8th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Utah Medical Earnings per Share Projection vs Actual
When determining whether Utah Medical Products is a strong investment it is important to analyze Utah Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Utah Medical's future performance. For an informed investment choice regarding Utah Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Utah Medical Products. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Utah Medical. If investors know Utah will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Utah Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.27) | Dividend Share 1.205 | Earnings Share 3.96 | Revenue Per Share | Quarterly Revenue Growth (0.26) |
The market value of Utah Medical Products is measured differently than its book value, which is the value of Utah that is recorded on the company's balance sheet. Investors also form their own opinion of Utah Medical's value that differs from its market value or its book value, called intrinsic value, which is Utah Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Utah Medical's market value can be influenced by many factors that don't directly affect Utah Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Utah Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Utah Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Utah Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.